Despite its prevalence and cardiovascular risk implications, only 25 percent of patients with<unk><unk><unk>  are actively being treated. The medical therapy aims to reduce the atherosclerotic risk factors which include diabetes mellitus, hypertension, dyslipidemia and smoking, to improve walking time and distance and to prevent the progression of the<unk><unk><unk>  and the need of invasive surgical procedures. All patients with<unk><unk><unk>  should be prescribed an antiplatelet agent.
Peripheral arterial disease medical therapy
Raynaud's phenomenon medical therapy
Atherosclerosis medical therapy
Varicose veins medical therapy
Diabetic neuropathy medical therapy
Diabetic foot medical therapy
Saphenous vein graft disease treatment
Deep vein thrombosis medical therapy